MTOR and urinary bladder carcinoma: A recent study that analyzed the mechanisms of resistance in temsirolimus-resistant and -sensitive (parental) RT112 and UMUC3 bladder cancer cell lines showed that the drug resistance was associated with increased tumor growth and invasion, enhanced expression of cell cycle proteins, and elevated phosphorylation of AKT/mTOR signaling proteins.